Skip to Content
Contact Form Map & Directions Videos

Author: Cal Warriner

Power Morcellator – A Deadly Twist

04/13/2015
Defective Medical Devices
BY

The power morcellator, a surgical device used to mince large masses of tissue inside the body so the material can be extracted through small incisions, has been the center of a debate in the medical community since the Food and Drug Administration (“FDA”) discouraged its use in April, 2014. The FDA discouraged the use […]

Read More

FDA Drug Approvals off the Charts for 2014

03/17/2015
Articles
BY

New Medications Meet Unmet Patient Needs The Food and Drug Administration’s approval of 41 novel new drugs in 2014 made it a banner year for the pharmaceutical industry. The class of 2014 included biologicals, drugs that treat cancer and infectious diseases (bacterial, fungal, parasitic and viral) and therapeutic drugs. The […]

Read More

Third Ethicon Bellwether Trial Set for March 2015

01/19/2015
Defective Medical Devices
BY

Judge Goodwin is presiding over seven different federal multidistrict litigation established for similar cases filed against various medical device manufacturers, including American Medical Systems, Boston Scientific, Coloplast Corp., Cook Medical, Ethicon , C.R. Bard, and Neomedic. Each of the complaints involves allegations by women who experienced painful complications following the […]

Read More

Punitive Damages Claims May Proceed Against Boston Scientific

01/7/2015
Defective Medical Devices
BY

Several plaintiffs that were implanted with Boston Scientific’s Obtryx transobturator Mid-Urethral Sling System alleged in their lawsuits that the manufacturer, Boston Scientific, ignored warning that devices containing polypropylene should not be implanted in humans. These plaintiffs assert that Boston Scientific was aware that the polypropylene used in the Obtryx device […]

Read More

Is mHealth “Big Pharma’s” Nemesis?

12/18/2014
Defective Drugs
BY

Marketing study after marketing study shows mobile is the future for all industries – “big pharma” included. But marketing study after marketing study also shows drug companies fall far behind in making their Web sites compatible with smartphones, tablets and other devices. One-third of Web sites belonging to 150 leading […]

Read More

Hear What Our Clients Have To Say

"Nick DeBellis obtained the maximum recovery of full insurance limits in the case we worked on. He is a true professional and recommend him to anyone in South Florida."
Posted By: Michael Geoffroy